186.47
+5.91
+(3.27%)
At close: April 11 at 6:57:35 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 19 | 25 | 24 |
| Avg. Estimate | 5.58B | 5.8B | 24.15B | 25.81B |
| Low Estimate | 5.49B | 5.63B | 24.01B | 25.45B |
| High Estimate | 5.92B | 5.95B | 24.59B | 26.27B |
| Year Ago Sales | 5.8B | 5.74B | 23.88B | 24.15B |
| Sales Growth (year/est) | -3.72% | 1.02% | 1.16% | 6.85% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0R2B.L | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Upgrade | Barclays: Equal-Weight to Overweight | 4/10/2025 |
| Upgrade | Stifel: Hold to Buy | 3/14/2025 |
| Downgrade | Raymond James: Outperform to Market Perform | 2/3/2025 |
| Maintains | Citigroup: Buy to Buy | 1/30/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/30/2025 |
| Maintains | Baird: Outperform to Outperform | 1/30/2025 |